Cargando…
Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis
BACKGROUND: Mesenchymal stem cell (MSC) therapy has emerged as a promising novel therapeutic strategy for managing inflammatory bowel disease (IBD) mainly via dampening inflammation, regulating immune disorders, and promoting mucosal tissue repair. However, in the process, the associated changes in...
Autores principales: | Liu, Airu, Wang, Xing, Liang, Xiaonan, Wang, Wenxin, Li, Chenyang, Qian, Jiaming, Zhang, Xiaolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478446/ https://www.ncbi.nlm.nih.gov/pubmed/36118029 http://dx.doi.org/10.3389/fcimb.2022.960208 |
Ejemplares similares
-
Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
por: Liu, Airu, et al.
Publicado: (2023) -
HucMSC-Exo Promote Mucosal Healing in Experimental Colitis by Accelerating Intestinal Stem Cells and Epithelium Regeneration via Wnt Signaling Pathway
por: Liang, Xiaonan, et al.
Publicado: (2023) -
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
por: Dong, Ruijuan, et al.
Publicado: (2020) -
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients
por: Zhu, Siying, et al.
Publicado: (2022) -
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
por: Wang, Zhilei, et al.
Publicado: (2022)